Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02312882 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02312882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, alopecia totalis, alopecia universalis